Viemed Q1 FY26 net income falls to USD 2.6 million; revenue rises 28% to USD 75.4 million

Viemed Healthcare, Inc.

VMD

0.00

Viemed Healthcare posted Q1 revenue of USD 75.4 million, up 28% year over year.
Net income attributable to shareholders totaled USD 2.6 million, or USD 0.06 per diluted share.
Adjusted EBITDA rose 12% to USD 14.3 million; prior-year results included a USD 2.7 million non-recurring gain tied to a ventilator return program that concluded in 2025.
PAP therapy patient count climbed 57% from a year earlier to 35,938, while ventilator patient count increased 2% to 12,089.
Full-year net revenue outlook narrowed and increased to USD 312 million-USD 320 million, while adjusted EBITDA guidance was reaffirmed at USD 65 million-USD 69 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viemed Healthcare Inc. published the original content used to generate this news brief on May 05, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.